CVS Health has stated it will return $43 million in funding it received for COVID-19 relief.

The nation’s largest commercial health insurer said the update took effect last month and applies to its policyholders with low or intermediate risk of coronary artery disease. 
 

The lab’s leaders are pledging to support innovators in various industries—including healthcare—who will have a hand in the rise of 5G technology.

New Jersey providers have been beset by a double whammy of financial challenges during the pandemic, with hospital expenses also increasing by $214 million per month. 

Hospitals and healthcare providers are facing higher costs to care for complex COVID-19 patients while also suffering the loss of other procedures like elective surgeries that could help offset these higher costs.

President Trump recently stated he was taking hydroxychloroquine, an anti-malaria drug that has been unproven to prevent or treat infection of COVID-19. Trump has touted the drug over the past several weeks for benefitting COVID-19 patients, but studies have shown little to no impact.

Such was the case in 2009, when the Great Recession brought about a “protracted, seven-year struggle” to recruit medical students into the specialty, experts wrote in Current Problems in Diagnostic Radiology. 

Jeffrey Klein, MD, a professor of radiology at the University of Vermont, highlighted a few of his reasons for remaining upbeat in a recently posted commentary.